Mersana Therapeutics Inc Financial Flexibility Index
Mersana Therapeutics Inc financial flexibility index. Mersana Therapeutics Inc (MRSN) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-3.19 Million (operating CF $-3.19 Million minus capex $0.00) represents 0% of total liabilities ($122.22 Million). See MRSN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Mersana Therapeutics Inc (2015–2024)
Financial flexibility index of Mersana Therapeutics Inc from 2015 to 2024. Historical Financial Flexibility Index trend for Mersana Therapeutics Inc across 10 annual periods. Check MRSN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Mersana Therapeutics Inc Financial Flexibility Index by Year (2015–2024)
Mersana Therapeutics Inc financial flexibility index by year from 2015 to 2024. Year-by-year free cash flow to debt coverage for Mersana Therapeutics Inc. For the full cash flow conversion analysis, see MRSN cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.53x | $-82.21 Million | $-82.34 Million | $154.17 Million | ▲ +39.5% |
| 2023 | -0.88x | $-166.71 Million | $-168.88 Million | $189.16 Million | ▼ -352.7% |
| 2022 | -0.19x | $-47.17 Million | $-49.36 Million | $242.28 Million | ▲ +88.2% |
| 2021 | -1.65x | $-139.34 Million | $-139.99 Million | $84.37 Million | ▼ -0.8% |
| 2020 | -1.64x | $-74.22 Million | $-74.70 Million | $45.31 Million | ▲ +28.7% |
| 2019 | -2.30x | $-67.14 Million | $-67.74 Million | $29.22 Million | ▼ -197.4% |
| 2018 | -0.77x | $-53.85 Million | $-55.22 Million | $69.71 Million | ▼ -12.9% |
| 2017 | -0.68x | $-41.54 Million | $-42.68 Million | $60.72 Million | ▼ -436.5% |
| 2016 | 0.20x | $32.67 Million | $31.59 Million | $160.71 Million | ▲ +228.7% |
| 2015 | -0.16x | $-9.02 Million | $-9.64 Million | $57.10 Million | — |